Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai 50200, Thailand.
Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai 50200, Thailand.
Pharmacol Res. 2021 Nov;173:105882. doi: 10.1016/j.phrs.2021.105882. Epub 2021 Sep 13.
Doxorubicin is an effective chemotherapeutic drug, but causes cardiotoxicity which limits its use. Oxidative stress, mitochondrial dysfunction, and inflammation are closely implicated in doxorubicin-induced cardiotoxicity (DIC). Necroptosis, a new form of programmed cell death, was also upregulated by doxorubicin, leading to cardiomyocyte death and cardiac dysfunction. Donepezil, an acetylcholinesterase inhibitor, exerted cardioprotection against various heart diseases. However, its cardioprotective effects in DIC are still unknown. We hypothesized that donepezil reduces reactive oxygen species (ROS) production, mitochondrial dysfunction, mitochondrial dynamics imbalance, necroptosis, and apoptosis in DIC rats. Male Wistar rats were assigned to receive either normal saline solution (n = 8) or doxorubicin (3 mg/kg, 6 doses, n = 16) via intraperitoneal injection. The doxorubicin-treated rats were further subdivided to receive either sterile drinking water (n = 8) or donepezil (5 mg/kg/day, p.o., n = 8) for 30 days. At the end of the experiment, the left ventricular (LV) function was determined. Serum and heart tissue were collected to evaluate histological and biochemical parameters. Doxorubicin-treated rats exhibited higher levels of inflammatory cytokines and ROS production. Doxorubicin also impaired mitochondrial function, mitochondrial dynamics balance, mitophagy, and autophagy, which culminated in apoptosis. Furthermore, doxorubicin increased necroptosis as evidenced by increased phosphorylation of receptor-interacting protein kinase 1, receptor-interacting protein kinase 3, and mixed-lineage kinase domain-like. All of these mechanisms led to LV dysfunction. Interestingly, donepezil alleviated mitochondrial injury, mitophagy, autophagy, and cardiomyocyte death, leading to improved LV function in DIC. In conclusion, donepezil attenuated DIC-induced LV dysfunction by reducing mitochondrial damage, mitophagy, autophagy, apoptosis, and necroptosis.
多柔比星是一种有效的化疗药物,但会导致心脏毒性,从而限制了其使用。氧化应激、线粒体功能障碍和炎症与多柔比星诱导的心脏毒性(DIC)密切相关。细胞程序性死亡的一种新形式——坏死性凋亡也被多柔比星上调,导致心肌细胞死亡和心脏功能障碍。多奈哌齐是一种乙酰胆碱酯酶抑制剂,对各种心脏病具有心脏保护作用。然而,其在 DIC 中的心脏保护作用尚不清楚。我们假设多奈哌齐可减少 DIC 大鼠中活性氧(ROS)的产生、线粒体功能障碍、线粒体动力学失衡、坏死性凋亡和细胞凋亡。雄性 Wistar 大鼠被分配接受生理盐水溶液(n=8)或多柔比星(3mg/kg,6 次剂量,n=16)腹腔注射。多柔比星处理的大鼠进一步分为接受无菌饮用水(n=8)或多奈哌齐(5mg/kg/天,口服,n=8)治疗 30 天。实验结束时,测定左心室(LV)功能。收集血清和心脏组织以评估组织学和生化参数。多柔比星处理的大鼠表现出更高水平的炎症细胞因子和 ROS 产生。多柔比星还损害了线粒体功能、线粒体动力学平衡、线粒体自噬和自噬,最终导致细胞凋亡。此外,多柔比星增加了坏死性凋亡,表现为受体相互作用蛋白激酶 1、受体相互作用蛋白激酶 3 和混合谱系激酶结构域样蛋白的磷酸化增加。所有这些机制都导致 LV 功能障碍。有趣的是,多奈哌齐减轻了线粒体损伤、线粒体自噬、自噬和心肌细胞死亡,从而改善了 DIC 中的 LV 功能。总之,多奈哌齐通过减少线粒体损伤、线粒体自噬、自噬、细胞凋亡和坏死性凋亡来减轻 DIC 引起的 LV 功能障碍。